
Liminal BioSciences LMNL
Quartalsbericht 2022-Q2
hinzugefügt 10.08.2022
Liminal BioSciences DIO 2011-2026 | LMNL
DIO Jährlich Liminal BioSciences
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| - | 1.68 K | 995 | 171 | 1.3 K | 738 | 244 | 135 | 166 | 82.2 | - |
Alle Zahlen in CAD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 1.68 K | 82.2 | 612 |
DIO anderer Aktien in der Pharmaeinzelhändler
| Name | DIO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Acorda Therapeutics
ACOR
|
345 | - | -24.86 % | $ 820 K | ||
|
Aptorum Group Limited
APM
|
4.89 | $ 0.79 | -1.15 % | $ 4.31 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
512 | - | - | $ 40.3 B | ||
|
ADMA Biologics
ADMA
|
316 | $ 15.36 | -2.17 % | $ 3.66 B | ||
|
Midatech Pharma plc
MTP
|
40.6 | - | -18.52 % | $ 27.3 M | ||
|
Институт стволовых клеток человека
ISKJ
|
275 | - | - | - | ||
|
Anika Therapeutics
ANIK
|
247 | $ 14.05 | -1.44 % | $ 206 M | ||
|
ANI Pharmaceuticals
ANIP
|
181 | $ 74.36 | -1.64 % | $ 1.44 B | ||
|
AVEO Pharmaceuticals
AVEO
|
63.8 | - | - | $ 521 M | ||
|
Axsome Therapeutics
AXSM
|
168 | $ 162.43 | 0.6 % | $ 8.08 B | ||
|
BioCryst Pharmaceuticals
BCRX
|
892 | $ 8.49 | -0.18 % | $ 1.75 B | ||
|
BridgeBio Pharma
BBIO
|
233 | $ 65.66 | -0.78 % | $ 12.6 B | ||
|
Acasti Pharma
ACST
|
136 | - | 4.01 % | $ 150 M | ||
|
BioDelivery Sciences International
BDSI
|
321 | - | -4.8 % | $ 255 M | ||
|
BeiGene, Ltd.
BGNE
|
304 | - | 0.49 % | $ 251 B | ||
|
Berkeley Lights
BLI
|
246 | - | -7.31 % | $ 87 M | ||
|
Aeterna Zentaris
AEZS
|
55.6 | - | 5.93 % | $ 314 M | ||
|
BioMarin Pharmaceutical
BMRN
|
644 | $ 61.3 | 1.21 % | $ 11.8 B | ||
|
Codexis
CDXS
|
50.2 | $ 1.23 | -2.38 % | $ 90.3 M | ||
|
Clovis Oncology
CLVS
|
271 | - | -7.23 % | $ 13 M |